PRODUCT DETAIL

Moxifloxacin Kabi 400 mg/250 ml infúzny roztok

Code

9820A

MA number

42/0150/14-S

Product Form:

sol inf 20x250 ml/400 mg (fľ.PE)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

Fresenius Kabi s.r.o., Czechia

Therapeutic Class:

42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)

ATC:

J	ANTIINFECTIVES FOR SYSTEMIC USE
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J01M	QUINOLONE ANTIBACTERIALS
J01MA	Fluoroquinolones
J01MA14	Moxifloxacin

Shelf life:

Route of admin.:

Intravenous use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	29.04.2014
Pediatric contraindication:	Yes
PIL:	PIL_Moxifloxacin Kabi 400 mg_250 ml sol inf-fľaša_05.2025.pdf
PIL:	PIL_Moxifloxacin Kabi 400 mg_250 ml sol inf-vak_05.2025.pdf
SPC:	SPC_Moxifloxacin Kabi 400 mg_250 ml sol inf_05.2025.pdf
Safety feature	Yes
Data update:	09.09.2019